Connecticut Compromise
Connecticut Compromise (also known as the Great Compromise of 1787 or Sherman's Compromise) was an agreement reached during the Constitutional Convention of 1787 that balanced the interests of small and large states. The compromise led to the creation of a bicameral legislature, with representation in the lower house based on population and equal representation for all states in the upper house.
Background[edit | edit source]
The United States was a new nation in the 1780s, and its government under the Articles of Confederation was seen as weak and ineffective. The Constitutional Convention was called in 1787 to address these issues and create a new constitution. However, the delegates from the small and large states disagreed on how representation should be determined in the new Congress.
The Compromise[edit | edit source]
The Connecticut Compromise was proposed by Roger Sherman and Oliver Ellsworth, delegates from Connecticut. They suggested a bicameral legislature, with one house (the House of Representatives) having representation based on population, and the other house (the Senate) having equal representation for all states, regardless of size. This compromise was accepted by the delegates and became part of the United States Constitution.
Impact[edit | edit source]
The Connecticut Compromise played a crucial role in shaping the U.S. government. It ensured that both small and large states had a voice in the federal government, and it established the structure of Congress that is still in use today. The compromise also set a precedent for resolving disputes between states with differing interests.
Criticism[edit | edit source]
Despite its success, the Connecticut Compromise has been criticized for giving too much power to smaller states. Critics argue that the equal representation in the Senate is undemocratic because it gives disproportionate influence to states with smaller populations.
See also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD